National Institutes of Health Stock
National Institutes of Health is a biomedical research facility in the United States that focuses on biomedical and health-related research.
Sign up today and learn more about National Institutes of Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About National Institutes of Health Stock
National Institutes of Health is a biomedical research facility in the United States. It is affiliated to the United States Department of Health and Human Services. It is the primary agency of the United States government responsible for biomedical and health-related research. It conducts its own scientific research through its Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program. National Institutes of Health has 1,200 principal investigators and more than 4,000 postdoctoral fellows in basic, translational, and clinical research. It comprises 27 separate institutes and centers that conduct research in different disciplines of biomedical science. With scientific accomplishments such as the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, the creation of vaccines against hepatitis, Haemophilus influenzae (HIB) and human papillomavirus, National Institutes of Health has many agencies under its control. National Institutes of Health was established in 1887. It is based in Bethesda, Maryland.
Funding History
August 2017 | $5.0M |
---|---|
September 2017 | $0 |
Management
Chief
Jose Galvez
Head - Molecular Genetics & Carcinogenesis Section
Curtis Harris
Scientific Advisory Board
Sanjiv Gambhir
Clinical Director
Avindra Nath
Senior Investigator
Yinling Hu
Director, The Cancer Genome Atlas Program Office
Jean Claude Zenklusen
Director
Samuel Broder
Founder
Joseph Kinyoun
Chief - Laboratory of Human Carcinogenesis
Curtis Harris
Invited Lecturer
Rob Paull
Press
bizjournals - Feb, 22 2024
Cornelius startup Phase receives $1.8M grant from National Institutes of Health for 3D-printing projectpubmed - Dec, 28 2023
A Systematic Review on Childhood Non-Hodgkin Lymphoma: An Overlooked Phenomenon in the Health and Research Sector of Bangladeshbizjournals - Oct, 17 2023
Palantir, Denver-area university receive $30M grant from National Institutes of Healthseekingalpha - Jul, 11 2023
Pluri stock soars on $4.2M contract from U.S. National Institutes of Healthjournalrecord - Jan, 23 2023
National Institutes of Health awards grant